|
|
Petmed Express Inc (PETS) |
|
Price: $7.2300
$-0.27 
-3.600%
|
| Day's High:
| $7.51
| Week Perf:
| -6.35 %
|
| Day's Low: |
$ 7.16 |
30 Day Perf: |
-23.09 % |
| Volume (M): |
452 |
52 Wk High: |
$ 22.64 |
| Volume (M$): |
$ 3,271 |
52 Wk Avg: |
$14.60 |
| Open: |
$7.51 |
52 Wk Low: |
$5.50 |
|
|
| Market Capitalization (Millions $) |
0 |
| Shares
Outstanding (Millions) |
0 |
| Employees |
193 |
| Revenues (TTM) (Millions $) |
270 |
| Net Income (TTM) (Millions $) |
-6 |
| Cash Flow (TTM) (Millions $) |
-43 |
| Capital Exp. (TTM) (Millions $) |
5 |
Petmed Express Inc
PetMed Express Inc is a leading nationwide online retailer of pet medications and supplies for dogs, cats, and horses.
The company's flagship website '1800PetMeds.com' offers prescription and non-prescription pet products for various health conditions like flea and tick control, heartworm prevention, arthritis, skin and coat care, dental hygiene, and much more.
PetMed Express was founded in 1996 and is headquartered in Delray Beach, Florida.
The company has a rich history of providing trusted, affordable, and convenient pet health care solutions.
PetMed Express sells its products through its website and toll-free number and has a customer base of over 10 million pet owners.
The company's business model is based on its longstanding relationships with some of the largest pharmaceutical companies in the world, which help it source the highest quality pet medications at competitive prices.
The company also prides itself on providing excellent customer service and has consistently been awarded 'Excellent' status by Bizrate, an accredited online customer rating agency.
PetMed Express' primary mission is to provide value to pet owners by offering high-quality pet medications and supplies at affordable prices.
The company strives to improve the quality of life of pets by offering products that can help manage and prevent common pet health conditions.
Furthermore, PetMed Express has a strong commitment to animal welfare and donates a portion of its profits to charities and animal rescue organizations.
The company has also provided support to various animal shelters and sanctuaries in times of natural disasters.
In terms of financials, PetMed Express reported net sales of $289.2 million in fiscal year 2020, an increase of 8.8% over the previous year.
The company continues to invest in its online platform and has launched a mobile app to make ordering pet supplies more convenient for customers.
Overall, PetMed Express Inc is a reputable company that offers a convenient and affordable solution for pet owners in need of prescription and non-prescription pet medications and supplies.
Company Address: 420 South Congress Avenue Delray Beach 33445 FL
Company Phone Number: 526-4444 Stock Exchange / Ticker: NASDAQ PETS
| PETS is expected to report next financial results on February 06, 2024. |
|
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
|
Bimi International Medical Inc
Bimi International Medical Inc, a renowned medical company, has recently announced its impressive financial results for the fiscal period ending on June 30, 2023. The company generated a substantial revenue of $5.557666 million, which indicates a significant growth in its operations. Moreover, Bimi International Medical Inc also exhibited an improving profit margin, with a net margin of 18.97% and an operating margin of 23.38%.
One notable aspect of their financial statement is the decline in net earnings compared to the corresponding period the previous year. While Bimi International Medical Inc recorded no profits in the previous period, the company experienced a decline in net earnings, which amounted to $1.054 million in the current period. Although this decline might seem alarming at first, the company's overall performance and the growth in revenue indicate that Bimi International Medical Inc is still on a positive trajectory.
|
|
Cosmos Health Inc
Cosmos Health Inc, a company trading on the NASDAQ, has experienced a decline in share prices over the past month, along with a significant drop compared to its 52-week average. However, recent positive developments have been observed, including an increase in COSM shares over the last five trading days. These contrasting trends and the third-quarter financial results indicate some challenges for Cosmos Health Inc, which may have ramifications for the company's future prospects.
1. Share Performance:
- Cosmos Health Inc shares have witnessed a decline of -2.7% over the past 30 days, suggesting a loss of investor confidence.
- COSM shares, on the other hand, have shown growth of 3.85% over the last five trading days, implying a short-term recovery for the company.
|
|
Trees Corporation
Financial News Report: Trees Corporation Reports Improved Earnings and Revenue Growth in Q3 2023
Trees Corporation, a leading Pharmacy Services and Retail Drugstore company, recently announced its financial results for the third quarter of 2023. The company showed significant improvements in earnings per share (EPS) and revenue growth compared to the same period in the previous year.
During the third quarter of 2023 earnings season, Trees Corporation reported a decrease in loss per share of $0.01, compared to a loss of $0.03 per share in the same period a year before. This represents a positive development for the company and demonstrates its efforts to reduce losses. Additionally, the EPS improved from -$0.02 in the preceding financial reporting period.
|
|
Petiq Inc
the third quarter financial results of PetIQ Inc. (NASDAQ: PETQ), a prominent pet medication and wellness company, have been released, investors are provided with substantial evidence of the company's improving financial health. According to the report for the July to September 30, 2023, time-frame, PetIQ Inc. has achieved remarkable improvements in various financial indicators.
First and foremost, the company's earnings turned positive in this period, with a significant increase from a loss of $-1.68 per share to a gain of $0.02 per share compared to the same period last year. This represents a remarkable recovery and reflects the successful implementation of the company's strategic initiatives.
|
|
Cardinal Health Inc
Cardinal Health Inc (CAH) experienced a challenging period in terms of earnings per share (EPS), with a significant decline of -95% to $0.02 per share in the first quarter of 2024. Despite this, the company saw impressive revenue growth of 10.403% to $54.76 billion compared to the same reporting period the previous year.
In the Pharmacy Services and Retail Drugstore sector, Cardinal Health Inc's revenue growth outpaced that of its contemporaries. Two-thirds of businesses in this industry experienced a top-line growth of 9.65% relative to the previous year.
|
| Per Share |
Current |
| Earnings (TTM) |
0.31 $ |
| Revenues (TTM) |
13225.89 $
|
| Cash Flow (TTM) |
- |
| Cash |
2623.32 $
|
| Book Value |
5576.76 $
|
| Dividend (TTM) |
0.9 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
0.31 $
|
| Revenues (TTM) |
13225.89 $ |
| Cash Flow (TTM) |
- |
| Cash |
2623.32 $
|
| Book Value |
5576.76 $ |
| Dividend (TTM) |
0.9 $ |
|
|
|
|
